Last 215.05 INR
Change Today +1.30 / 0.61%
Volume 102.5K
As of 7:06 AM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

j.b. chemicals & pharma ltd (JBCP) Snapshot

Open
215.80
Previous Close
213.75
Day High
224.00
Day Low
212.95
52 Week High
09/9/14 - 257.90
52 Week Low
10/25/13 - 92.35
Market Cap
18.2B
Average Volume 10 Days
165.7K
EPS TTM
7.26
Shares Outstanding
84.8M
EX-Date
09/4/14
P/E TM
29.6x
Dividend
3.00
Dividend Yield
1.40%
Current Stock Chart for J.B. CHEMICALS & PHARMA LTD (JBCP)

Related News

No related news articles were found.

j.b. chemicals & pharma ltd (JBCP) Related Businessweek News

No Related Businessweek News Found

j.b. chemicals & pharma ltd (JBCP) Details

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and APIs in India. The company offers generic products and formulations in the form of tablets, capsules, creams and ointments, injectables, liquid herbal syrups, and lozenges. It also manufactures iodinated contrast media, which are radiopaque substances used to study internal structures of the body in X-ray procedures, such as computed tomography and cardiac catheterization. In addition, the company’s APIs include atenolol USP, cilnidipine, diclofenac acid, and diclofenac diethylamine BP/EP. Further, it provides contract manufacturing services to pharmaceutical companies. The company also exports its products primarily to Russia, Ukraine, CIS countries, and South Africa. J. B. Chemicals & Pharmaceuticals Limited was founded in 1976 and is headquartered in Mumbai, India.

Founded in 1976

j.b. chemicals & pharma ltd (JBCP) Top Compensated Officers

Chairman, Managing Director and Member of Sha...
Total Annual Compensation: 16.0M
President, Director of Operations and Whole-T...
Total Annual Compensation: 7.7M
Director of Technical & Production and Execut...
Total Annual Compensation: 4.4M
Director of Administration, Whole-Time Direct...
Total Annual Compensation: 16.0M
Director of Planning & Development and Whole-...
Total Annual Compensation: 7.7M
Compensation as of Fiscal Year 2014.

j.b. chemicals & pharma ltd (JBCP) Key Developments

J. B. Chemicals & Pharmaceuticals Ltd. Approves the Alteration in the Article of Association

J. B. Chemicals & Pharmaceuticals Ltd. at its AGM held on September 15, 2014, approved the alteration of Article of Association of the company.

J. B. Chemicals & Pharmaceuticals Ltd., Annual General Meeting, Sep 15, 2014

J. B. Chemicals & Pharmaceuticals Ltd., Annual General Meeting, Sep 15, 2014., at 15:30 Indian Standard Time. Location: RAMA WATUMULL AUDITORIUM. Agenda: To consider and adopt the audited balance sheet as at March 31, 2014, the profit and loss account for the year ended on that date together with the reports of the board of directors and the auditors thereon; to consider declare a dividend on equity shares; to consider the appoint a director in place of Mr. Shirish B. Mody who retires by rotation and, being eligible, offers himself for re-appointment; to consider the appoint a director in place of Mr. Kamlesh L. Udani who retires by rotation and, being eligible, offers himself for re-appointment; to consider the appoint auditors and to fix their remuneration, and in this regard to consider and if thought fit, to pass, with or without modifications, the following resolution as an ordinary resolution; to consider the appointment of Ms. Krupa R. Gandhi as Independent Director and to consider, and if thought fit, to pass, with or without modifications, the following resolution as an ordinary resolution; and to consider other matters.

J. B. Chemicals & Pharmaceuticals Ltd. Announces Unaudited Earnings Results for First Quarter Ended June 30, 2014

J. B. Chemicals & Pharmaceuticals Ltd. announced unaudited earnings results for first quarter ended June 30, 2014. For the quarter, the company reported net sales/income from operations of INR 2,567.121 million, total income from operations of INR 2,626.028 million, profit from operations before other income, finance costs and exceptional items of INR 384.531 million, profit before tax of INR 425.547 million, net profit of INR 317.910 million or INR 3.75 per basic and diluted share compared to the net sales/income from operations of INR 2,291.667 million, total income from operations of INR 2,352.280 million, profit from operations before other income, finance costs and exceptional items of INR 328.882 million, profit before tax of INR 274.930 million, net profit of INR 203.254 million or INR 2.40 per basic and diluted share for the same quarter a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JBCP:IN 215.05 INR +1.30

JBCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JBCP.
View Industry Companies
 

Industry Analysis

JBCP

Industry Average

Valuation JBCP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact J.B. CHEMICALS & PHARMA LTD, please visit www.jbcpl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.